Back to Search
Start Over
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
- Source :
- Journal of the American Academy of Dermatology, JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante, instname, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
- Subjects :
- Adult
Male
2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
prospective cohort
MEDLINE
Dermatology
registry
immunosuppressive agents
Severity of Illness Index
COVID-19 (Malaltia)
Article
Cohort Studies
Internal medicine
Pandemic
Psoriasis
Humans
Medicine
biologic therapy
Registries
Aged
business.industry
Incidence
Incidence (epidemiology)
COVID-19
COVID-19, Psoriasis, biologic therapy, immunosuppressive agents, pharmacovigilance, prospective cohort, registry
Middle Aged
Spain
pharmacovigilance
Female
business
Psoriasi -- Tractament
Cohort study
Subjects
Details
- Language :
- English
- ISSN :
- 01909622
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology
- Accession number :
- edsair.doi.dedup.....6ee85e20c554b0bcaee6a5631e05665f
- Full Text :
- https://doi.org/10.1016/j.jaad.2020.10.046